It's surprising how much pharmaceutical research to date has been more art than science. Computing power is still a long way off predicting the properties of proteins and cells from their DNA, so until then the more research that can be accelerated by automation (e.g. lab robots, lab-on-chip) the better.
And this is being driven by the big pharma companies who can't afford the failure rate at late stage drug development, or worse after release which can result in multi-billion law suits. I attended an excellenty talk by the chief scientific office for GE Healthcare recently and they are mass producing stem cell lines, and the machinery to test them, so that drugs can be tested for cardio-toxicity much earlier on in the development process.
Seres Therapeutics is developing revolutionary microbiome-based therapeutics to treat serious diseases.
Pharmaceutical company that develops a novel class of medicines by targeting damaged cells.
Fast generation of functional therapeutic antibodies.
Software platform to accelerate innovation in the pharmaceutical industry.
Generic pharmaceutical company.
Company focused on Pharmaceutical Drug Formulation manufacturing, Development and marketing of finished dosage.
US-based manufacturer of generic drugs.
Manufacturer of generic medicines.
A global pharmaceutical company.
Leading manufacturer of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs) in Bangladesh.
Laboratory Automation Blog Posts
Robotic scientists can do lab work faster
BBC - 06-Jul-2020
Does not mean that machines will be able to replace human scientistsRead more...
Automated manufacturing of custom-engineered cell lines
News Medical - 20-May-2020
This technology is very promising and has an enormous potentialRead more...
COVID-19 advanced testing lab created by UC Berkeley scientists
University of California, Berkeley - 30-Mar-2020
In response to mass testing needs, they employ robotics and automation for accuracy and speedRead more...